A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
Recruiting
Observational Study
Heart Failure With Preserved Ejection Fraction
Coronary Microvascular Dysfunction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 25 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18
* Enrollment in main CS-reducer HFPEF study IRB# 25-002292
Exclusion Criteria:
* Metal implants that are not suitable for MRI
* Inability or unwillingness of individual to give written informed consent.
Contacts